Ascendis Pharma A/S (FRA:A71)

Ascendis Pharma Revenue

Ascendis Pharma had revenue of 246.60M EUR in the quarter ending March 31, 2026, with 144.27% growth. This brings the company's revenue in the last twelve months to 865.78M, up 134.82% year-over-year. In the year 2025, Ascendis Pharma had annual revenue of 720.13M with 98.03% growth.

• Revenue (ttm): 865.78M
• Revenue Growth: +134.82%
• P/S Ratio: 16.91
• Revenue / Employee: 605.66K
• Employees: 1,189
• Market Cap: 12.18B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	720.13M	356.49M	98.03%
Dec 31, 2024	363.64M	96.92M	36.34%
Dec 31, 2023	266.72M	215.54M	421.20%
Dec 31, 2022	51.17M	43.40M	557.93%
Dec 31, 2021	7.78M	825.00K	11.87%
Dec 31, 2020	6.95M	-6.42M	-48.01%
Dec 31, 2019	13.38M	2.79M	26.41%
Dec 31, 2018	10.58M	9.05M	591.57%
Dec 31, 2017	1.53M	-3.08M	-66.78%
Dec 31, 2016	4.61M	-3.51M	-43.26%
Dec 31, 2015	8.12M	-5.87M	-41.94%
Dec 31, 2014	13.98M	-6.43M	-31.48%
Dec 31, 2013	20.41M	4.83M	30.96%
Dec 31, 2012	15.58M	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 20, 2026

Data Sources Report a data error